AJP - Lung AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (December 23, 2004). doi:10.1152/ajplung.00420.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/L805    most recent
00420.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frankel, S. K.
Right arrow Articles by Riches, D. W.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frankel, S. K.
Right arrow Articles by Riches, D. W.H.
Submitted on November 9, 2004
Accepted on December 17, 2004

Human Insulin-Like Growth Factor-IA Expression in Transgenic Mice Promotes Adenomatous Hyperplasia but not Pulmonary Fibrosis

Stephen K. Frankel1, Billie M. Moats-Staats2, Carlyne D. Cool3, Murry W. Wynes4, Alan D. Stiles2, and David W.H. Riches5*

1 Department of Medicine, National Jewish Medical and Research Center, Denver, CO, USA; Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA
2 Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA
3 Department of Medicine, National Jewish Medical and Research Center, Denver, CO, USA; Department of Pathology, University of Colorado Health Sciences Center, Denver, CO, USA
4 Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, USA; Department of Immunology, University of Colorado Health Sciences Center, Denver, CO, USA
5 Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, USA; Department of Medicine, National Jewish Medical and Research Center, Denver, CO, USA; Department of Immunology, University of Colorado Health Sciences Center, Denver, CO, USA

* To whom correspondence should be addressed. E-mail: richesd{at}njc.org.

Insulin-like growth factor-I (IGF-I) has been implicated in post-natal alveolar development, pulmonary fibrosis and non-small cell lung cancer. To further investigate the role of IGF-I, we created a line of transgenic mice in which alveolar type II epithelial cells express human IGF-IA under the control of the SP-C promoter. We determined the effect of pulmonary over-expression of human IGF-IA on i) pulmonary inflammation and fibrosis in response to intra-tracheal instillation of bleomycin, ii) pre-malignant pulmonary adenomatous hyperplasia and iii) adenoma formation. Transgenic expression of human IGF-IA had no effect on baseline gross lung pathology, cellularity of bronchoalveolar lavage or total lung collagen content. In addition, there were no significant differences between transgenic mice and non-transgenic littermate controls in the development of pulmonary inflammation or pulmonary fibrosis in response to intratracheal bleomycin instillation. However, pulmonary expression of human IGF-IA in older mice (> 12 months) significantly increased the incidence of pre-malignant adenomatous hyperplastic lesions compared to littermate controls without affecting adenoma formation. These findings suggest that increased expression of human IGF-IA in alveolar airspaces does not affect the development of pulmonary fibrosis, but promotes pre-malignant changes in the alveolar epithelium.




This article has been cited by other articles:


Home page
Cancer Res.Home page
W.-Y. Kim, Q. Jin, S.-H. Oh, E. S. Kim, Y. J. Yang, D. H. Lee, L. Feng, C. Behrens, L. Prudkin, Y. E. Miller, et al.
Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development
Cancer Res., September 15, 2009; 69(18): 7439 - 7448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-E. Choi, S.-s. Lee, D. A. Sunde, I. Huizar, K. L. Haugk, V. J. Thannickal, R. Vittal, S. R. Plymate, and L. M. Schnapp
Insulin-like Growth Factor-I Receptor Blockade Improves Outcome in Mouse Model of Lung Injury
Am. J. Respir. Crit. Care Med., February 1, 2009; 179(3): 212 - 219.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
P. D. Ryan and P. E. Goss
The Emerging Role of the Insulin-Like Growth Factor Pathway as a Therapeutic Target in Cancer
Oncologist, January 1, 2008; 13(1): 16 - 24.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. P. Stabile, J. S. Lyker, S. R. Land, S. Dacic, B. A. Zamboni, and J. M. Siegfried
Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer
Carcinogenesis, August 1, 2006; 27(8): 1547 - 1555.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. Chua, J. Gauldie, and G. J. Laurent
Pulmonary Fibrosis: Searching for Model Answers
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 9 - 13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. A. Feghali-Bostwick
IGF-I: mediator of fibrosis or carcinogenesis?
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L803 - L804.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.